Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200066977Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) comparing Dronedarone group with Amiodarone group (2 arms). Primary endpoint: Late recurrence. Planned start Dec 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200066977.